Wolfe Research has identified DoorDash (DASH) as one of its top stock picks. This recommendation highlights the firm's positive outlook on the food delivery company.

Wolfe Research reports that ongoing uncertainty surrounding COVID-19 continues to negatively impact the financial outlook for pharmaceutical giant Pfizer (PFE).

Wolfe Research has reduced its price target for ServiceNow (NOW) stock.

According to Wolfe Research, the adoption of artificial intelligence is growing, but its implementation remains primarily focused within specific industry sectors.

Wolfe Research has initiated coverage of BeOne Medicines AG (ONC) with an "Outperform" rating.

Following analysts' suggestions that Nvidia's $1 trillion orders guidance is a floor, not a ceiling, market sentiment indicates that the company's rally is expected to continue with significant future growth.

Wolfe Research has downgraded Starbucks to a neutral rating, citing an increasingly competitive coffee market.

Wolfe Research has identified several stocks with consistent dividend payments and solid track records, suggesting they could become dividend aristocrats amidst market volatility.

Wolfe Research has reiterated its focus on Nvidia's leading position in artificial intelligence, emphasizing the company's continued dominance in the sector.

Wolfe Research suggests that the market's reaction to Eli Lilly's (LLY) Foundayo report appears to be excessive, indicating a potential overcorrection in the stock price.

Wolfe Research has reportedly lifted its price target for Moody's (MCO) stock, indicating a positive outlook for the company's shares.

Wolfe Research has expressed a bullish outlook on The Home Depot, Inc. (HD), even amidst a general market downturn.

Wolfe Research has reiterated its "Buy" rating for Nvidia (NVDA), signaling continued confidence in the technology company's stock performance.

Fastenal (FAST) has been included in Wolfe Research's favorites list, identified as a key play in the ongoing manufacturing recovery.

Wolfe Research has increased its price target for Amazon, attributing the positive outlook to the strong performance of its AWS business, particularly from investments in AI and data centers.

Off-price retailers, such as Dollar General, are anticipated to be most severely affected by a projected surge in gasoline prices, according to Wolfe Research, which could impact consumer spending habits.

Several financial firms have issued new ratings, price targets, or coverage initiations for biotech and pharmaceutical companies including Beam Therapeutics, Krystal Biotech, 4D Molecular Therapeutics, BioMarin Pharmaceutical, Vertex Pharmaceuticals, CRISPR Therapeutics AG, Regeneron Pharmaceuticals, and UniQure.

Wolfe Research has reiterated its 'Outperform' rating for RTX Corp following the company's deal with the Pentagon for a missile manufacturing framework.

Wolfe Research has issued a warning about potential risks posed by central bank policies, particularly as oil prices continue to remain elevated. The analysis suggests a complex interplay between monetary policy and commodity markets.

Wolfe Research maintains a 'buy' rating on Five Below, setting a $291 price target and suggesting a potential 26% surge in shares, partly due to the company's focus on popular products.

Wolfe Research suggests that companies with a consistent history of buying back their own stock can provide investors with a strategic advantage during volatile market periods.

Wolfe Research has upgraded its rating for Brinker International (EAT), the parent company of Chili's and Maggiano's Little Italy, to 'Outperform'.

Wolfe Research has highlighted its preferred dividend stocks, noting that market volatility has boosted their appeal, and provided a list of buy ideas.

Wolfe Research has noted conviction-driven opportunities within ACADIA Pharmaceuticals Inc.’s (ACAD) therapeutic domains, suggesting potential for growth.

Wolfe Research has adopted a bearish stance on Circle Internet Group (CRCL), citing lower EBITDA expectations.